Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis
Abstract The prophylactic vaccines available to protect against infections by HPV are well tolerated and highly immunogenic. People with HIV have a higher risk of developing HPV infection and HPV-associated cancers due to a lower immune response, and due to viral interactions. We performed a systema...
Guardado en:
Autores principales: | Antonella Zizza, Federico Banchelli, Marcello Guido, Claudia Marotta, Francesco Di Gennaro, Walter Mazzucco, Vanna Pistotti, Roberto D’Amico |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b5b7b5931194c2fa5814cc004b011d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human papillomavirus vaccination: evidence base for efficacy and safety
por: Yuliya E. Dobrokhotova, et al.
Publicado: (2021) -
Safety and efficacy of RNA vaccines: State of the art
por: A. V. Blagov, et al.
Publicado: (2021) -
Treatment of human papillomavirus infection in HIV-infected patients
por: V. S. Smirnov, et al.
Publicado: (2021) -
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
por: Aruna Chandran, et al.
Publicado: (2010) -
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.
por: Walter Jaoko, et al.
Publicado: (2010)